Trials / Completed
CompletedNCT06270511
A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants
A Phase 1, 2-Part Study to Evaluate the Relative Bioavailability of and Food-Effect on Pharmacokinetics of Different Formulations of S-337395, and to Assess the Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of S-337395 in Healthy Adult Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Shionogi · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to investigate different formulations of S-337395.
Detailed description
This single-center study comprises an open-label, randomized, crossover study, and a double-blinded, placebo-controlled, randomized, multiple-dose study to examine the relative bioavailability, food effect, pharmacokinetics, safety, and tolerability of different formulations of S-337395.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | S-337395 | Administered as an oral suspension. |
| DRUG | Placebo | Administered as an oral suspension. |
Timeline
- Start date
- 2024-03-13
- Primary completion
- 2024-05-30
- Completion
- 2024-06-19
- First posted
- 2024-02-21
- Last updated
- 2024-07-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06270511. Inclusion in this directory is not an endorsement.